CD8A and neoplasm: Tumor-specific T CD8 cells are the core cellular components that exert anti-tumor effects in TME, which can dynamically respond to tumor antigen peptides presented by major histocompatibility complex II (MHC II) molecules in the presence of costimulatory or coinhibitory factors68.